Software to Pharma
Paul Joubert, CPA, has joined Phase Forward’s board of directors. Joubert is currently a founding partner of EdgeAdvisors, a privately held management consulting organization, and a director of Stream Global Services, Inc.
He previously spent over 35 years with PricewaterhouseCoopers (PwC), an international accounting firm.
Bob Weiler, chairman and chief executive officer of Phase Forward, remarked, "Phase Forward is fortunate to add a senior executive with Paul's vast experience to our board of directors. In addition to his financial expertise, Paul has a long history of advising technology companies on strategic initiatives to enhance and sustain growth with the goal of building shareholder value. As Phase Forward continues to grow organically and through strategic acquisitions, we believe Paul's contributions will be invaluable."
"Phase Forward is a clear market leader and it is setting the vision for the evolution of clinical trial and drug safety solutions," said Joubert. "I look forward to using my business and financial background to add value to what is already a very strong and diverse board of directors at Phase Forward."
Joubert joined PricewaterhouseCoopers in 1971 and has worked extensively with both public and private companies in start-up to mature stages of growth in the high technology, manufacturing and service industries. Joubert retired from PwC in June 2008, most recently serving as partner in the firm's Assurance practice. Joubert's previous roles at PwC include leading the firm's Technology, InfoCom and Entertainment practice for the Northeast region of the United States and serving as chief of staff to the Vice-Chairman of domestic operations.
Joubert has been a frequent speaker and author on business and financial topics. He is a graduate of Northeastern University, where he received a bachelor of science in finance and accounting. Joubert is a member of various civic and professional associations including the Association for Corporate Growth, a former director and treasurer of the Massachusetts Innovation and Technology Exchange and he serves on the Board of Overseers of the Museum of Science. He is also a member of the American Institute of Certified Public Accountants.
About Phase Forward:
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm™), phase I clinic automation (LabPas™), clinical data management (Clintrial™), clinical trials signal detection (CTSD™), strategic pharmacovigilance (Empirica™ Signal) and Signal Management, adverse event reporting (Empirica™ Trace), applied data standards (WebSDM™) and Web-integrated interactive response technologies (Clarix™). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 280 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.